Bryan Terry Smedley, DO - Medicare Otolaryngology in Owasso, OK

Bryan Terry Smedley, DO is a medicare enrolled "Otolaryngology - Otolaryngology/facial Plastic Surgery" physician in Owasso, Oklahoma. He went to Arizona College Of Osteopathic Medicine Mid Western University and graduated in 2010 and has 14 years of diverse experience with area of expertise as Otolaryngology. He is a member of the group practice Brian G Lee Md Pllc and his current practice location is 10512 N 110th East Ave, Suite 210, Owasso, Oklahoma. You can reach out to his office (for appointments etc.) via phone at (918) 376-8996.

Bryan Terry Smedley is licensed to practice in Oklahoma (license number 5118) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1275822926.

Contact Information

Bryan Terry Smedley, DO
10512 N 110th East Ave, Suite 210,
Owasso, OK 74055-6636
(918) 376-8996
(918) 376-8990



Physician's Profile

Full NameBryan Terry Smedley
GenderMale
SpecialityOtolaryngology
Experience14 Years
Location10512 N 110th East Ave, Owasso, Oklahoma
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Bryan Terry Smedley attended and graduated from Arizona College Of Osteopathic Medicine Mid Western University in 2010
  NPI Data:
  • NPI Number: 1275822926
  • Provider Enumeration Date: 04/04/2011
  • Last Update Date: 01/08/2016
  Medicare PECOS Information:
  • PECOS PAC ID: 3375858608
  • Enrollment ID: I20190918000015

Medical Identifiers

Medical identifiers for Bryan Terry Smedley such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1275822926NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207YX0905XOtolaryngology - Otolaryngology/facial Plastic Surgery 5118 (Oklahoma)Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Brian G Lee Md Pllc408291424710

News Archive

Siemens announces FDA 510(k) clearance for Xprecia Stride Coagulation Analyzer

Siemens Healthineers has more than 30 years of central lab hemostasis leadership. Building on to its portfolio, the company announced today FDA 510(k) clearance for a hand-held portable coagulation analyzer.

RXi Pharmaceuticals reports positive results from second Phase 1 study with RXI‑109

RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced positive results from their second placebo-controlled Phase 1 study with RXI‑109, an sd-rxRNA compound that targets Connective Tissue Growth Factor, and is being developed for the treatment of abnormal dermal scars such as hypertrophic scars and keloids in conjunction with scar revision surgery.

Diabetic nerve pain: Most bothersome complication of diabetes

In a new online survey, eighty-five percent of people who experience diabetic nerve pain said that their pain was one of the top three most bothersome complications of their diabetes. Despite the fact that people with diabetic nerve pain recognize the condition's impact on their lives and eighty-four percent of those surveyed said they have discussed the condition with a healthcare provider, just slightly less than half of respondents (49 percent) were treating their pain.

Extra sunlight in late summer could help reduce severity of flu season

People getting more rays of sunlight -; and therefore vitamin D -; in August and September could help reduce the severity of flu season, according to a National Bureau of Economic Research working paper co-authored by a University of Kansas economist.

Labopharm announces European approval of twice-daily tramadol-acetaminophen

Labopharm Inc. today announced its twice-daily tramadol-acetaminophen has received a positive opinion under the European Union Decentralized Procedure in eight countries (Czech Republic, Iceland, Ireland, Poland, Portugal, Slovakia, Slovenia and Spain). Marketing Authorization will be granted in each country subject to the approval of translations of the Summary of Product Characteristics (SPC) and other labeling documents.

Read more Medical News

› Verified 6 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Bryan Terry Smedley allows following entities to bill medicare on his behalf.
Entity NameArizona Center For Hematology And Oncology Plc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1841243722
PECOS PAC ID: 8123007747
Enrollment ID: O20040716001063

News Archive

Siemens announces FDA 510(k) clearance for Xprecia Stride Coagulation Analyzer

Siemens Healthineers has more than 30 years of central lab hemostasis leadership. Building on to its portfolio, the company announced today FDA 510(k) clearance for a hand-held portable coagulation analyzer.

RXi Pharmaceuticals reports positive results from second Phase 1 study with RXI‑109

RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced positive results from their second placebo-controlled Phase 1 study with RXI‑109, an sd-rxRNA compound that targets Connective Tissue Growth Factor, and is being developed for the treatment of abnormal dermal scars such as hypertrophic scars and keloids in conjunction with scar revision surgery.

Diabetic nerve pain: Most bothersome complication of diabetes

In a new online survey, eighty-five percent of people who experience diabetic nerve pain said that their pain was one of the top three most bothersome complications of their diabetes. Despite the fact that people with diabetic nerve pain recognize the condition's impact on their lives and eighty-four percent of those surveyed said they have discussed the condition with a healthcare provider, just slightly less than half of respondents (49 percent) were treating their pain.

Extra sunlight in late summer could help reduce severity of flu season

People getting more rays of sunlight -; and therefore vitamin D -; in August and September could help reduce the severity of flu season, according to a National Bureau of Economic Research working paper co-authored by a University of Kansas economist.

Labopharm announces European approval of twice-daily tramadol-acetaminophen

Labopharm Inc. today announced its twice-daily tramadol-acetaminophen has received a positive opinion under the European Union Decentralized Procedure in eight countries (Czech Republic, Iceland, Ireland, Poland, Portugal, Slovakia, Slovenia and Spain). Marketing Authorization will be granted in each country subject to the approval of translations of the Summary of Product Characteristics (SPC) and other labeling documents.

Read more Medical News

› Verified 6 days ago

Entity NameBrian G Lee Md Pllc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1811365703
PECOS PAC ID: 4082914247
Enrollment ID: O20151120000550

News Archive

Siemens announces FDA 510(k) clearance for Xprecia Stride Coagulation Analyzer

Siemens Healthineers has more than 30 years of central lab hemostasis leadership. Building on to its portfolio, the company announced today FDA 510(k) clearance for a hand-held portable coagulation analyzer.

RXi Pharmaceuticals reports positive results from second Phase 1 study with RXI‑109

RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced positive results from their second placebo-controlled Phase 1 study with RXI‑109, an sd-rxRNA compound that targets Connective Tissue Growth Factor, and is being developed for the treatment of abnormal dermal scars such as hypertrophic scars and keloids in conjunction with scar revision surgery.

Diabetic nerve pain: Most bothersome complication of diabetes

In a new online survey, eighty-five percent of people who experience diabetic nerve pain said that their pain was one of the top three most bothersome complications of their diabetes. Despite the fact that people with diabetic nerve pain recognize the condition's impact on their lives and eighty-four percent of those surveyed said they have discussed the condition with a healthcare provider, just slightly less than half of respondents (49 percent) were treating their pain.

Extra sunlight in late summer could help reduce severity of flu season

People getting more rays of sunlight -; and therefore vitamin D -; in August and September could help reduce the severity of flu season, according to a National Bureau of Economic Research working paper co-authored by a University of Kansas economist.

Labopharm announces European approval of twice-daily tramadol-acetaminophen

Labopharm Inc. today announced its twice-daily tramadol-acetaminophen has received a positive opinion under the European Union Decentralized Procedure in eight countries (Czech Republic, Iceland, Ireland, Poland, Portugal, Slovakia, Slovenia and Spain). Marketing Authorization will be granted in each country subject to the approval of translations of the Summary of Product Characteristics (SPC) and other labeling documents.

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Bryan Terry Smedley is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Bryan Terry Smedley, DO
10512 N 110th East Ave, Ste 200,
Owasso, OK 74055-6638

Ph: (918) 376-8996
Bryan Terry Smedley, DO
10512 N 110th East Ave, Suite 210,
Owasso, OK 74055-6636

Ph: (918) 376-8996

News Archive

Siemens announces FDA 510(k) clearance for Xprecia Stride Coagulation Analyzer

Siemens Healthineers has more than 30 years of central lab hemostasis leadership. Building on to its portfolio, the company announced today FDA 510(k) clearance for a hand-held portable coagulation analyzer.

RXi Pharmaceuticals reports positive results from second Phase 1 study with RXI‑109

RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced positive results from their second placebo-controlled Phase 1 study with RXI‑109, an sd-rxRNA compound that targets Connective Tissue Growth Factor, and is being developed for the treatment of abnormal dermal scars such as hypertrophic scars and keloids in conjunction with scar revision surgery.

Diabetic nerve pain: Most bothersome complication of diabetes

In a new online survey, eighty-five percent of people who experience diabetic nerve pain said that their pain was one of the top three most bothersome complications of their diabetes. Despite the fact that people with diabetic nerve pain recognize the condition's impact on their lives and eighty-four percent of those surveyed said they have discussed the condition with a healthcare provider, just slightly less than half of respondents (49 percent) were treating their pain.

Extra sunlight in late summer could help reduce severity of flu season

People getting more rays of sunlight -; and therefore vitamin D -; in August and September could help reduce the severity of flu season, according to a National Bureau of Economic Research working paper co-authored by a University of Kansas economist.

Labopharm announces European approval of twice-daily tramadol-acetaminophen

Labopharm Inc. today announced its twice-daily tramadol-acetaminophen has received a positive opinion under the European Union Decentralized Procedure in eight countries (Czech Republic, Iceland, Ireland, Poland, Portugal, Slovakia, Slovenia and Spain). Marketing Authorization will be granted in each country subject to the approval of translations of the Summary of Product Characteristics (SPC) and other labeling documents.

Read more News

› Verified 6 days ago


Otolaryngology Doctors in Owasso, OK


Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.